Latest CTMX reports update at 2024-05-08: 2024-Q12023-Q1
CytomX Therapeutics logo
CytomX Therapeutics CTMX
$ 1.38 -5.48%

CytomX Therapeutics EV/EBITDA Ratio 2011-2024 | CTMX

Annual EV/EBITDA Ratio CytomX Therapeutics

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-3.71 -2.8 -1.44 -5.92 -18.9 -5.29 -2.35 - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-1.44 -18.9 -5.77